ICOSLG anticorps (C-Term)
Aperçu rapide pour ICOSLG anticorps (C-Term) (ABIN951266)
Antigène
Voir toutes ICOSLG AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 216-246, C-Term
-
Specificité
- This antibody recognizes Human CD275 / ICOS Ligand (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 216-246 amino acids from the C-terminal region of human CD275 / ICOS Ligand
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
-
Autre désignation
- CD275 / ICOS Ligand
-
Sujet
- Ligand for the T-cell-specific cell surface receptor ICOS. Acts as a costimulatory signal for T-cell proliferation and cytokine secretion, induces also B-cell proliferation and differentiation into plasma cells. Could play an important role in mediating local tissue responses to inflammatory conditions, as well as in modulating the secondary immune response by co-stimulating memory T-cell function (By similarity).Synonyms: B7 homolog 2, B7-like protein Gl50, B7-related protein 1, B7H2, B7RP-1, B7RP1, ICOSL, ICOSLG, KIAA0653
-
Poids moléculaire
- 33349 Da
-
ID gène
- 23308
-
NCBI Accession
- NP_056074
-
Pathways
- Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Antigène
-